“…Understanding the impact of the different HbOCs on peripheral blood cells is desirable, as some HbOCs are undergoing Phase III clinical trials and may shortly become therapeutic agents for use in humans. Previous studies have shown that Hb solutions produced some in vitro modifications in RBC behavior, including changes in aggregation tendency 2,3 . However, the influence of Hb solutions on WBC activation and behavior has not been extensively investigated, although in vitro studies have shown that cell‐free Hb stimulates MNCs, leading to the release of IL‐6, IL‐8, and TNFα and to an increase in their procoagulant activity 4,5 …”